Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

Curb your enthusiasm (if you want to impress)

How do you build trust in pharmaceutical marketing? Through what you say, not by how loud you shout.

Life Healthcare Communications

- PMLiVE

Celgene says no to Mereo’s cancer drug etigilimab

UK biotech will focus on rare disease drugs

- PMLiVE

Digital division NHSX looks to improve experience for doctors as well as patients

Patient and public buy-in for data use essential

- PMLiVE

AbbVie’s upadacitinib tops Humira again in arthritis trial

Firm says pipeline drug only JAK inhibitor to show superiority

- PMLiVE

Syncona start-up Quell Therapeutics appoints chief exec

Biotech focusing on Tregs

- PMLiVE

Aimmune wins over ICER for peanut allergy product

Analysts predict blockbuster status for first-in-class

- PMLiVE

Sobi takes ownership of rare disease drug Gamifant for $518m

Fulfils rare disease firm's global expansion plans

- PMLiVE

£1 billion cuts to public health must be reversed, say charities

Cuts already having impact

- PMLiVE

EMD Serono allies with ‘free sequencing’ firm Nebula

Free genomic sequencing in exchange for data use

- PMLiVE

Type 1 diabetes prevention promise sends Provention Bio soaring

Remarkable results prompt firm to consider regulatory pathway

- PMLiVE

Orkambi row: government now considering Crown Use licensing

MPs call for radical solutions as deadlock remains

- PMLiVE

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

Novo looking to challenge with oral semaglutide

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links